CB2 Receptor Activation Inhibits Melanoma Cell Transmigration through the Blood-Brain Barrier

During parenchymal brain metastasis formation tumor cells need to migrate through cerebral endothelial cells, which form the morphological basis of the blood-brain barrier (BBB). The mechanisms of extravasation of tumor cells are highly uncharacterized, but in some aspects recapitulate the diapedesi...

Full description

Bibliographic Details
Main Authors: János Haskó, Csilla Fazakas, Judit Molnár, Ádám Nyúl-Tóth, Hildegard Herman, Anca Hermenean, Imola Wilhelm, Yuri Persidsky, István A. Krizbai
Format: Article
Language:English
Published: MDPI AG 2014-05-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:http://www.mdpi.com/1422-0067/15/5/8063
_version_ 1811339802301169664
author János Haskó
Csilla Fazakas
Judit Molnár
Ádám Nyúl-Tóth
Hildegard Herman
Anca Hermenean
Imola Wilhelm
Yuri Persidsky
István A. Krizbai
author_facet János Haskó
Csilla Fazakas
Judit Molnár
Ádám Nyúl-Tóth
Hildegard Herman
Anca Hermenean
Imola Wilhelm
Yuri Persidsky
István A. Krizbai
author_sort János Haskó
collection DOAJ
description During parenchymal brain metastasis formation tumor cells need to migrate through cerebral endothelial cells, which form the morphological basis of the blood-brain barrier (BBB). The mechanisms of extravasation of tumor cells are highly uncharacterized, but in some aspects recapitulate the diapedesis of leukocytes. Extravasation of leukocytes through the BBB is decreased by the activation of type 2 cannabinoid receptors (CB2); therefore, in the present study we sought to investigate the role of CB2 receptors in the interaction of melanoma cells with the brain endothelium. First, we identified the presence of CB1, CB2(A), GPR18 (transcriptional variant 1) and GPR55 receptors in brain endothelial cells, while melanoma cells expressed CB1, CB2(A), GPR18 (transcriptional variants 1 and 2), GPR55 and GPR119. We observed that activation of CB2 receptors with JWH-133 reduced the adhesion of melanoma cells to the layer of brain endothelial cells. JWH-133 decreased the transendothelial migration rate of melanoma cells as well. Our results suggest that changes induced in endothelial cells are critical in the mediation of the effect of CB2 agonists. Our data identify CB2 as a potential target in reducing the number of brain metastastes originating from melanoma.
first_indexed 2024-04-13T18:31:59Z
format Article
id doaj.art-192c0195582447399030155ce6a925f7
institution Directory Open Access Journal
issn 1422-0067
language English
last_indexed 2024-04-13T18:31:59Z
publishDate 2014-05-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-192c0195582447399030155ce6a925f72022-12-22T02:35:02ZengMDPI AGInternational Journal of Molecular Sciences1422-00672014-05-011558063807410.3390/ijms15058063ijms15058063CB2 Receptor Activation Inhibits Melanoma Cell Transmigration through the Blood-Brain BarrierJános Haskó0Csilla Fazakas1Judit Molnár2Ádám Nyúl-Tóth3Hildegard Herman4Anca Hermenean5Imola Wilhelm6Yuri Persidsky7István A. Krizbai8Institute of Biophysics, Biological Research Centre of the Hungarian Academy of Sciences, P.O. Box 521, Szeged H-6701, HungaryInstitute of Biophysics, Biological Research Centre of the Hungarian Academy of Sciences, P.O. Box 521, Szeged H-6701, HungaryInstitute of Biophysics, Biological Research Centre of the Hungarian Academy of Sciences, P.O. Box 521, Szeged H-6701, HungaryInstitute of Biophysics, Biological Research Centre of the Hungarian Academy of Sciences, P.O. Box 521, Szeged H-6701, HungaryInstitute of Life Sciences, Vasile Goldis Western University of Arad, Arad 310414, RomaniaInstitute of Life Sciences, Vasile Goldis Western University of Arad, Arad 310414, RomaniaInstitute of Biophysics, Biological Research Centre of the Hungarian Academy of Sciences, P.O. Box 521, Szeged H-6701, HungaryDepartment of Pathology and Laboratory Medicine, Temple University School of Medicine, Philadelphia, PA 19140, USAInstitute of Biophysics, Biological Research Centre of the Hungarian Academy of Sciences, P.O. Box 521, Szeged H-6701, HungaryDuring parenchymal brain metastasis formation tumor cells need to migrate through cerebral endothelial cells, which form the morphological basis of the blood-brain barrier (BBB). The mechanisms of extravasation of tumor cells are highly uncharacterized, but in some aspects recapitulate the diapedesis of leukocytes. Extravasation of leukocytes through the BBB is decreased by the activation of type 2 cannabinoid receptors (CB2); therefore, in the present study we sought to investigate the role of CB2 receptors in the interaction of melanoma cells with the brain endothelium. First, we identified the presence of CB1, CB2(A), GPR18 (transcriptional variant 1) and GPR55 receptors in brain endothelial cells, while melanoma cells expressed CB1, CB2(A), GPR18 (transcriptional variants 1 and 2), GPR55 and GPR119. We observed that activation of CB2 receptors with JWH-133 reduced the adhesion of melanoma cells to the layer of brain endothelial cells. JWH-133 decreased the transendothelial migration rate of melanoma cells as well. Our results suggest that changes induced in endothelial cells are critical in the mediation of the effect of CB2 agonists. Our data identify CB2 as a potential target in reducing the number of brain metastastes originating from melanoma.http://www.mdpi.com/1422-0067/15/5/8063blood-brain barrier (BBB)cerebral metastasismelanomacannabinoidCB2
spellingShingle János Haskó
Csilla Fazakas
Judit Molnár
Ádám Nyúl-Tóth
Hildegard Herman
Anca Hermenean
Imola Wilhelm
Yuri Persidsky
István A. Krizbai
CB2 Receptor Activation Inhibits Melanoma Cell Transmigration through the Blood-Brain Barrier
International Journal of Molecular Sciences
blood-brain barrier (BBB)
cerebral metastasis
melanoma
cannabinoid
CB2
title CB2 Receptor Activation Inhibits Melanoma Cell Transmigration through the Blood-Brain Barrier
title_full CB2 Receptor Activation Inhibits Melanoma Cell Transmigration through the Blood-Brain Barrier
title_fullStr CB2 Receptor Activation Inhibits Melanoma Cell Transmigration through the Blood-Brain Barrier
title_full_unstemmed CB2 Receptor Activation Inhibits Melanoma Cell Transmigration through the Blood-Brain Barrier
title_short CB2 Receptor Activation Inhibits Melanoma Cell Transmigration through the Blood-Brain Barrier
title_sort cb2 receptor activation inhibits melanoma cell transmigration through the blood brain barrier
topic blood-brain barrier (BBB)
cerebral metastasis
melanoma
cannabinoid
CB2
url http://www.mdpi.com/1422-0067/15/5/8063
work_keys_str_mv AT janoshasko cb2receptoractivationinhibitsmelanomacelltransmigrationthroughthebloodbrainbarrier
AT csillafazakas cb2receptoractivationinhibitsmelanomacelltransmigrationthroughthebloodbrainbarrier
AT juditmolnar cb2receptoractivationinhibitsmelanomacelltransmigrationthroughthebloodbrainbarrier
AT adamnyultoth cb2receptoractivationinhibitsmelanomacelltransmigrationthroughthebloodbrainbarrier
AT hildegardherman cb2receptoractivationinhibitsmelanomacelltransmigrationthroughthebloodbrainbarrier
AT ancahermenean cb2receptoractivationinhibitsmelanomacelltransmigrationthroughthebloodbrainbarrier
AT imolawilhelm cb2receptoractivationinhibitsmelanomacelltransmigrationthroughthebloodbrainbarrier
AT yuripersidsky cb2receptoractivationinhibitsmelanomacelltransmigrationthroughthebloodbrainbarrier
AT istvanakrizbai cb2receptoractivationinhibitsmelanomacelltransmigrationthroughthebloodbrainbarrier